Copyright Reports & Markets. All rights reserved.

Global Durvalumab Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Industry Overview of Durvalumab

    • 1.1 Brief Introduction of Durvalumab
    • 1.2 Classification of Durvalumab
    • 1.3 Applications of Durvalumab
    • 1.4 Market Analysis by Countries of Durvalumab
      • 1.4.1 United States Status and Prospect (2014-2024)
      • 1.4.2 Canada Status and Prospect (2014-2024)
      • 1.4.3 Germany Status and Prospect (2014-2024)
      • 1.4.4 France Status and Prospect (2014-2024)
      • 1.4.5 UK Status and Prospect (2014-2024)
      • 1.4.6 Italy Status and Prospect (2014-2024)
      • 1.4.7 Russia Status and Prospect (2014-2024)
      • 1.4.8 Spain Status and Prospect (2014-2024)
      • 1.4.9 China Status and Prospect (2014-2024)
      • 1.4.10 Japan Status and Prospect (2014-2024)
      • 1.4.11 Korea Status and Prospect (2014-2024)
      • 1.4.12 India Status and Prospect (2014-2024)
      • 1.4.13 Australia Status and Prospect (2014-2024)
      • 1.4.14 New Zealand Status and Prospect (2014-2024)
      • 1.4.15 Southeast Asia Status and Prospect (2014-2024)
      • 1.4.16 Middle East Status and Prospect (2014-2024)
      • 1.4.17 Africa Status and Prospect (2014-2024)
      • 1.4.18 Mexico East Status and Prospect (2014-2024)
      • 1.4.19 Brazil Status and Prospect (2014-2024)
      • 1.4.20 C. America Status and Prospect (2014-2024)
      • 1.4.21 Chile Status and Prospect (2014-2024)
      • 1.4.22 Peru Status and Prospect (2014-2024)
      • 1.4.23 Colombia Status and Prospect (2014-2024)

    2 Major Manufacturers Analysis of Durvalumab

    • 2.1 Company 1
      • 2.1.1 Company Profile
      • 2.1.2 Product Picture and Specifications
      • 2.1.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.1.4 Contact Information
    • 2.2 Company 2
      • 2.2.1 Company Profile
      • 2.2.2 Product Picture and Specifications
      • 2.2.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.2.4 Contact Information
    • 2.3 Company 3
      • 2.3.1 Company Profile
      • 2.3.2 Product Picture and Specifications
      • 2.3.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.3.4 Contact Information
    • 2.4 Company 4
      • 2.4.1 Company Profile
      • 2.4.2 Product Picture and Specifications
      • 2.4.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.4.4 Contact Information
    • 2.5 Company 5
      • 2.5.1 Company Profile
      • 2.5.2 Product Picture and Specifications
      • 2.5.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.5.4 Contact Information
    • 2.6 Company 6
      • 2.6.1 Company Profile
      • 2.6.2 Product Picture and Specifications
      • 2.6.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.6.4 Contact Information
    • 2.7 Company 7
      • 2.7.1 Company Profile
      • 2.7.2 Product Picture and Specifications
      • 2.7.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.7.4 Contact Information
    • 2.8 Company 8
      • 2.8.1 Company Profile
      • 2.8.2 Product Picture and Specifications
      • 2.8.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.8.4 Contact Information
    • 2.9 Company 9
      • 2.9.1 Company Profile
      • 2.9.2 Product Picture and Specifications
      • 2.9.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.9.4 Contact Information
    • 2.10 Company 10
      • 2.10.1 Company Profile
      • 2.10.2 Product Picture and Specifications
      • 2.10.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.10.4 Contact Information

    . . .

      3 Global Price, Sales and Revenue Analysis of Durvalumab by Regions, Manufacturers, Types and Applications

      • 3.1 Global Sales and Revenue of Durvalumab by Regions 2014-2019
      • 3.2 Global Sales and Revenue of Durvalumab by Manufacturers 2014-2019
      • 3.3 Global Sales and Revenue of Durvalumab by Types 2014-2019
      • 3.4 Global Sales and Revenue of Durvalumab by Applications 2014-2019
      • 3.5 Sales Price Analysis of Global Durvalumab by Regions, Manufacturers, Types and Applications in 2014-2019

      4 North America Sales and Revenue Analysis of Durvalumab by Countries

      • 4.1. North America Durvalumab Sales and Revenue Analysis by Countries (2014-2019)
      • 4.2 United States Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 4.3 Canada Durvalumab Sales, Revenue and Growth Rate (2014-2019)

      5 Europe Sales and Revenue Analysis of Durvalumab by Countries

      • 5.1. Europe Durvalumab Sales and Revenue Analysis by Countries (2014-2019)
      • 5.2 Germany Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 5.3 France Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 5.4 UK Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 5.5 Italy Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 5.6 Russia Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 5.7 Spain Durvalumab Sales, Revenue and Growth Rate (2014-2019)

      6 Asia Pacifi Sales and Revenue Analysis of Durvalumab by Countries

      • 6.1. Asia Pacifi Durvalumab Sales and Revenue Analysis by Countries (2014-2019)
      • 6.2 China Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 6.3 Japan Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 6.4 Korea Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 6.5 India Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 6.6 Australia Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 6.7 New Zealand Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 6.8 Southeast Asia Durvalumab Sales, Revenue and Growth Rate (2014-2019)

      7 Latin America Sales and Revenue Analysis of Durvalumab by Countries

      • 7.1. Latin America Durvalumab Sales and Revenue Analysis by Countries (2014-2019)
      • 7.2 Mexico Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 7.3 Brazil Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 7.4 C. America Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 7.5 Chile Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 7.6 Peru Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 7.7 Colombia Durvalumab Sales, Revenue and Growth Rate (2014-2019)

      8 Middle East & Africa Sales and Revenue Analysis of Durvalumab by Countries

      • 8.1. Middle East & Africa Durvalumab Sales and Revenue Analysis by Countries (2014-2019)
      • 8.2 Middle East Durvalumab Sales, Revenue and Growth Rate (2014-2019)
      • 8.3 Africa Durvalumab Sales, Revenue and Growth Rate (2014-2019)

      9 Global Market Forecast of Durvalumab by Regions, Countries, Manufacturers, Types and Applications

      • 9.1 Global Sales and Revenue Forecast of Durvalumab by Regions 2019-2024
      • 9.2 Global Sales and Revenue Forecast of Durvalumab by Manufacturers 2019-2024
      • 9.3 Global Sales and Revenue Forecast of Durvalumab by Types 2019-2024
      • 9.4 Global Sales and Revenue Forecast of Durvalumab by Applications 2019-2024
      • 9.5 Global Revenue Forecast of Durvalumab by Countries 2019-2024
        • 9.5.1 United States Revenue Forecast (2019-2024)
        • 9.5.2 Canada Revenue Forecast (2019-2024)
        • 9.5.3 Germany Revenue Forecast (2019-2024)
        • 9.5.4 France Revenue Forecast (2019-2024)
        • 9.5.5 UK Revenue Forecast (2019-2024)
        • 9.5.6 Italy Revenue Forecast (2019-2024)
        • 9.5.7 Russia Revenue Forecast (2019-2024)
        • 9.5.8 Spain Revenue Forecast (2019-2024)
        • 9.5.9 China Revenue Forecast (2019-2024)
        • 9.5.10 Japan Revenue Forecast (2019-2024)
        • 9.5.11 Korea Revenue Forecast (2019-2024)
        • 9.5.12 India Revenue Forecast (2019-2024)
        • 9.5.13 Australia Revenue Forecast (2019-2024)
        • 9.5.14 New Zealand Revenue Forecast (2019-2024)
        • 9.5.15 Southeast Asia Revenue Forecast (2019-2024)
        • 9.5.16 Middle East Revenue Forecast (2019-2024)
        • 9.5.17 Africa Revenue Forecast (2019-2024)
        • 9.5.18 Mexico East Revenue Forecast (2019-2024)
        • 9.5.19 Brazil Revenue Forecast (2019-2024)
        • 9.5.20 C. America Revenue Forecast (2019-2024)
        • 9.5.21 Chile Revenue Forecast (2019-2024)
        • 9.5.22 Peru Revenue Forecast (2019-2024)
        • 9.5.23 Colombia Revenue Forecast (2019-2024)

      10 Industry Chain Analysis of Durvalumab

      • 10.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Durvalumab
        • 10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Durvalumab
        • 10.1.2 Major Equipment Suppliers with Contact Information Analysis of Durvalumab
      • 10.2 Downstream Major Consumers Analysis of Durvalumab
      • 10.3 Major Suppliers of Durvalumab with Contact Information
      • 10.4 Supply Chain Relationship Analysis of Durvalumab

      11 New Project Investment Feasibility Analysis of Durvalumab

      • 11.1 New Project SWOT Analysis of Durvalumab
      • 11.2 New Project Investment Feasibility Analysis of Durvalumab
        • 11.2.1 Project Name
        • 11.2.2 Investment Budget
        • 11.2.3 Project Product Solutions
        • 11.2.4 Project Schedule

      12 Conclusion of the Global Durvalumab Industry Market Research 2019

        13 Appendix

        • 13.1 Research Methodology
          • 13.1.1 Methodology/Research Approach
          • 13.1.2 Data Source
        • 13.2 Author Details

        The Durvalumab market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Durvalumab.
        Global Durvalumab industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and growth rate), gross margin, major manufacturers, development trends and forecast.

        Key players in global Durvalumab market include:
        Medimmune (AstraZeneca)

        Market segmentation, by product types:
        2.4mL Injection
        10mL Injection

        Market segmentation, by applications:
        Locally Advanced Urothelial Carcinoma
        Metastatic Urothelial Carcinoma
        Other

        Market segmentation, by regions:
        North America (United States, Canada)
        Europe (Germany, France, UK, Italy, Russia, Spain)
        Asia Pacific (China, Japan, Korea, India, Australia, New Zealand)
        Middle East & Africa (Middle East, Africa)
        Latin America (Mexico, Brazil, C. America, Chile, Peru, Colombia)

        The report can answer the following questions:
        1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Durvalumab industry.
        2. Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of Durvalumab industry.
        3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Durvalumab industry.
        4. Different types and applications of Durvalumab industry, market share of each type and application by revenue.
        5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Durvalumab industry.
        6. Upstream raw materials and manufacturing equipment, industry chain analysis of Durvalumab industry.
        7. SWOT analysis of Durvalumab industry.
        8. New Project Investment Feasibility Analysis of Durvalumab industry.
        Buy now